RxDoctor Payments Data

Amanda Cartee, MD

Gastroenterology · Ann Arbor, MINPI 1194161760

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,529 of the $4,790 with a category attached, or 94.6%. Sanofi US Services Inc. accounts for 94.6% of it on its own, with 6 other manufacturers making up the rest.

$4,790in general payments, 2019–2025

Across 9 payments — averaging $532.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$5K
  • Medtronic$127
  • Conmed Corporation$40
  • Olympus America Inc.$26
  • Takeda Pharmaceuticals U.S.A., Inc.$24
  • E.r. Squibb & Sons, L.L.C.$22
  • plus $20 from 1 others
$146,245in research payments, 2019–2025

Across 29 payments — averaging $5042.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Takeda Pharmaceuticals U.S.A., Inc.$146K

What the payments were for

  • Consulting fees$4,52995%
  • Food & beverage$2605%

General payments by program year

19
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,790 in reported general payments places this provider in the 70th percentile of 497 gastroenterology providers in Michigan.

See all gastroenterology providers in Michigan

Medicare billing

Part B allowed, 2024
$36,171
Medicare patients
193
Services billed
344

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide11$12,355
Colestipol Hcl24$1,176
Budesonide DrBudesonide13$1,054
Omeprazole55$1,018
Mirtazapine19$936
Nortriptyline Hcl18$232
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl14$198
Buspirone Hcl12$83

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →